CLINICAL_TRIALS
withdrawal
· 2016-11-22
Clinical Trial Update: Randomized AmnioFix Study During Radical Prostatectomy [Phase 2]
Summary
A randomized Phase 2 trial evaluating AmnioFix during radical prostatectomy for prostate cancer has been withdrawn. The sponsor is MD Anderson Cancer Center, an…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: WITHDRAWN